Kainos Progresses Parkinson’s Drug US Trials Amid Deal Prospects

US Phase II Study Of FAF1 Inhibitor Begins

Parkinson's Disease
Could KM-819 Be The First Disease Modifying Drug For Parkinson’s? • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from R&D

More from Scrip